Ashley T. Martino, Ph.D.
Affiliations: | 2007 | University of Florida, Gainesville, Gainesville, FL, United States |
Area:
Genetics, Molecular Biology, Microbiology BiologyGoogle:
"Ashley Martino"Parents
Sign in to add mentor| Shouguang Jin | grad student | 2007 | UF Gainesville | |
| (Treating an N-glycosylation abnormality in airways with a cystic fibrosis transmembrane conductance regulator protein deficiency reduces Pseudomonas aeruginosa colonization; A hallmark symptom of cystic fibrosis.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Markusic DM, Martino AT, Porada CD, et al. (2020) Immunology of Gene and Cell Therapy. Molecular Therapy : the Journal of the American Society of Gene Therapy |
| Martino AT, Markusic DM. (2020) Immune Response Mechanisms against AAV Vectors in Animal Models. Molecular Therapy. Methods & Clinical Development. 17: 198-208 |
| Herzog RW, Cooper M, Perrin GQ, et al. (2017) Regulatory T cells and TLR9 activation shape antibody formation to a secreted transgene product in AAV muscle gene transfer. Cellular Immunology |
| Carrig S, Wopat MJ, Martino AT. (2016) 550. Developing an Optimal Insulin Augmentation Therapy to Improve AAV Gene Transfer to Skeletal Muscle and Liver in Mice Molecular Therapy. 24 |
| Carrig SM, Bijjiga E, Martino AT. (2015) 681. Increasing Insulin Activity During AAV (Adeno-Associated Virus) Administration to Muscle Improves Gene Transfer in Mice Molecular Therapy. 23 |
| Basner-Tschakarjan E, Bijjiga E, Martino AT. (2014) Pre-Clinical Assessment of Immune Responses to Adeno-Associated Virus (AAV) Vectors. Frontiers in Immunology. 5: 28 |
| Rogers GL, Martino AT, Zolotukhin I, et al. (2014) Role of the vector genome and underlying factor IX mutation in immune responses to AAV gene therapy for hemophilia B. Journal of Translational Medicine. 12: 25 |
| Martino AT, Basner-Tschakarjan E, Markusic DM, et al. (2013) Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cells. Blood. 121: 2224-33 |
| Markusic DM, Martino AT, Mingozzi F, et al. (2012) In Vivo Model to Evaluate Loss of Liver-Derived Factor IX Expression Caused by AAV Capsid-Specific CD8+ T Cells Blood. 120: 2046-2046 |
| Martino AT, Herzog RW, Anegon I, et al. (2011) Measuring immune responses to recombinant AAV gene transfer. Methods in Molecular Biology (Clifton, N.J.). 807: 259-72 |